Merios
Lipids

ApoB 90 mg/dL: Is That Optimal or Borderline?

ApoB 90 mg/dL is borderline: at the expert threshold for intermediate risk, above the 80 mg/dL high-risk goal. What 90 means and how to get under 80.

OCT 12, 20265 MIN READLIPIDSMERIOS EDITORIAL
Contents
  1. Is ApoB 90 mg/dL Optimal or Risky?
  2. Where Does 90 mg/dL Fall?
  3. Why ApoB Beats LDL Cholesterol
  4. How to Lower ApoB from 90 to Under 80
  5. What to Recheck and When
  6. How Merios Tracks This
  7. Related Reading
  8. Sources

Is ApoB 90 mg/dL Optimal or Risky?

ApoB 90 mg/dL is borderline — not optimal, not yet high. You're sitting right at the National Lipid Association's treatment threshold for people at borderline-to-intermediate risk (an ApoB of 90 mg/dL corresponds to an LDL-C of about 100 mg/dL) and above the European goal of <80 mg/dL for high-risk people.12 It's a signal that lifestyle adjustments (and possibly lipid-lowering therapy down the road) deserve attention now, while the trajectory is still cheap to change.

Where Does 90 mg/dL Fall?

CategoryApoB goal or threshold (mg/dL)
Very high risk (NLA threshold / ESC/EAS goal)<60 / <65
High risk (NLA threshold / ESC/EAS goal)<70 / <80
Borderline-to-intermediate risk (NLA threshold)<90
Your value (90 mg/dL)Borderline
Moderate risk (ESC/EAS goal)<100

These figures come from the National Lipid Association's 2024 expert consensus and the 2019 ESC/EAS guidelines.12 For people with established cardiovascular disease and other very-high-risk profiles, the bar drops to <60–65 mg/dL.

Why ApoB Beats LDL Cholesterol

Most clinicians still focus on LDL-C, but ApoB counts the number of atherogenic particles — and the number of particles is what causes plaque, not the cholesterol they carry.34

Two patients can have identical LDL-C of 100 mg/dL with very different ApoB counts. The one with higher ApoB (more, smaller particles) carries meaningfully higher cardiovascular risk despite the same cholesterol number.1 The 2019 ESC/EAS guidelines set ApoB goals alongside LDL-C goals, and the 2026 ACC/AHA guideline uses ApoB to check for leftover risk once LDL-C goals are met.25

Read more: ApoB: Your Real Heart Risk Number.

How to Lower ApoB from 90 to Under 80

ApoB responds to lifestyle, though each change moves it only modestly. The biggest levers, ranked by evidence:

  1. Reduce saturated fat to <7% of calories — the first dietary step in US guidelines. Swap butter, fatty meat, full-fat dairy for olive oil, fish, nuts; swapping saturated for unsaturated fat lowers both LDL-C and ApoB.67
  2. Add 10–25 g/day soluble fiber — oats, beans, lentils, psyllium, chia. Soluble fiber binds bile acids, forcing the liver to pull cholesterol from circulation; in trials, about 10 g/day of psyllium lowered ApoB by roughly 5 mg/dL.689
  3. 3–4 sessions/week zone-2 cardio + 2 strength sessions — improves lipid metabolism and insulin sensitivity.1011
  4. Drop excess body fat — even 5–10% body weight loss improves your lipid profile.12
  5. Omega-3 fatty acids (EPA/DHA, 2–4 g/day) — lowers triglycerides; at prescription doses of 4 g/day, ApoB fell only modestly.13

If after 12 weeks of consistent lifestyle change ApoB is still ≥80, talk to your physician about a low-dose statin or bempedoic acid. For people with established CVD or very high Lp(a), starting medication earlier is usually the right call.5

What to Recheck and When

  • Recheck ApoB at 12 weeks after starting changes
  • Also check Lp(a) once in your life (genetic; doesn't change with lifestyle)514
  • Track hs-CRP alongside — chronic inflammation adds to cardiovascular risk15

If your 12-week recheck shows ApoB has dropped below 80, you've reached even the European goal for high-risk people. If still 85+, that's the signal to escalate — either intensify lifestyle or add medication.

How Merios Tracks This

Merios pulls ApoB from any standard lipid panel PDF (Quest, LabCorp, Function, your PCP) and tracks it longitudinally alongside Lp(a), hs-CRP, ApoA1, and the full lipid subfractionation. The Merios Score shows whether your cardiovascular pillar is improving over time, not just at one snapshot.

Try Merios free →

Sources

15 references · checked October 12, 2026

  1. Soffer DE, Marston NA, Maki KC, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol, 2024.PMID 39256087DOI
  2. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020.PMID 31504418DOI
  3. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol, 2019.PMID 31642874DOI
  4. Marston NA, Giugliano RP, Melloni GEM, et al. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. JAMA Cardiol, 2022.PMID 34773460DOI
  5. Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2026.PMID 41824552DOI
  6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001.PMID 11368702DOI
  7. Koutsos A, Griffin BA, Antoni R, et al. Variation of LDL cholesterol in response to the replacement of saturated with unsaturated fatty acids: a nonrandomized, sequential dietary intervention; the Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention ("RISSCI"-1) study. Am J Clin Nutr, 2024.PMID 39111551DOI
  8. Gunness P, Gidley MJ. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct, 2010.PMID 21776465DOI
  9. Jovanovski E, Yashpal S, Komishon A, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr, 2018.PMID 30239559DOI
  10. Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA, 2018.PMID 30418471DOI
  11. Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Prev Med, 2009.PMID 19013187DOI
  12. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation, 2014.PMID 24222017DOI
  13. Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. Circulation, 2019.PMID 31422671DOI
  14. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J, 2022.PMID 36036785DOI
  15. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003.PMID 12551878DOI

Frequently asked questions

  • Is ApoB 90 mg/dL bad?
    Not bad, but not optimal. ApoB 90 mg/dL sits right at the National Lipid Association's treatment threshold for people at borderline-to-intermediate risk and above the European goal of <80 mg/dL for high-risk people. It signals you have more atherogenic particles than ideal — a meaningful nudge to act before the number drifts higher.
  • What's the optimal ApoB level?
    It depends on your risk. The National Lipid Association uses ApoB thresholds of 90 mg/dL for borderline-to-intermediate risk, 70 mg/dL for high risk and 60 mg/dL for very high risk (for example, after a heart attack). European guidelines set goals of <100, <80 and <65 mg/dL for moderate, high and very high risk.
  • How fast can I lower ApoB from 90 to under 80?
    Lifestyle changes (lower saturated fat, more soluble fiber, regular cardio + strength) lower ApoB modestly; soluble fiber alone trims only a few mg/dL. Statins lower ApoB by about a third on average, somewhat less than they lower LDL-C. Recheck after 12 weeks to confirm.
Keep reading

More from the Journal

Lipids

ApoB: Your Real Heart Risk Number (Not LDL) [2026 Guide]

Cardiologists are paying more attention to ApoB for good reason. Why LDL misleads in about 1 in 5 people + exact targets.

APR 16, 20269 MIN READ
Lipids

Total Cholesterol 220: Is This Too High?

Total cholesterol 220 is borderline high, but the number alone is misleading. Your LDL, HDL, and triglycerides matter far more.

APR 24, 20266 MIN READ
Lipids

Cholesterol Ratio Calculator: Total/HDL, LDL/HDL and Triglyceride/HDL

Calculate and interpret your cholesterol ratios — Total/HDL, LDL/HDL, and Triglyceride/HDL — and why the Trig/HDL ratio best flags insulin resistance.

APR 17, 20268 MIN READ
Newsletter

Like this? Get the next one in your inbox.

Merios is live on the US App Store — plus a weekly briefing with new biomarker deep-dives and plain-English study breakdowns.

Get the app